About Progressive supranuclear palsy-progressive non-fluent aphasia syndrome
Progressive supranuclear palsy-progressive non-fluent aphasia syndrome is a rare disease catalogued by Orphanet (ORPHA:240112). It is associated with the MAPT gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Progressive supranuclear palsy-progressive non-fluent aphasia syndrome trials.
Search ClinicalTrials.gov for "Progressive supranuclear palsy-progressive non-fluent aphasia syndrome" or filter by Orphanet code ORPHA:240112 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Progressive supranuclear palsy-progressive non-fluent aphasia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Progressive supranuclear palsy-progressive non-fluent aphasia syndrome. Updated daily.